PMID- 21625828 OWN - NLM STAT- MEDLINE DCOM- 20110920 LR - 20191112 IS - 1868-8551 (Electronic) IS - 1868-596X (Linking) VI - 28 IP - 2 DP - 2011 TI - Local lymph node assay: how testing laboratories apply OECD TG 429 for REACH purposes. PG - 117-29 AB - The Local Lymph Node Assay (LLNA) is the official method for assessing the allergic contact dermatitis potential of chemicals for the purposes of REACH regulation. The LLNA went through a validation process that allowed the delineation of a robust protocol for performing new tests. The OECD accepted this method in 2002 and published OECD TG 429. The European Chemical Agency (ECHA) recently published data that were submitted in the registration dossiers of chemicals. This database was analysed to determine how testing laboratories apply OECD TG 429. This analysis comes after a detailed analysis of four full study reports that were also prepared for REACH purposes. Although the majority of the tests are fully compliant with OECD TG 429, some showed major deviations, and a number of others used more animals than necessary. This suggests that in vivo tests need to be planned more carefully and consciously to obtain meaningful results with the minimum animal number necessary. FAU - Rovida, Costanza AU - Rovida C AD - CAAT-Europe, University of Konstanz, Germany. costanza.rovida@chimici.it LA - eng PT - Journal Article PL - Germany TA - ALTEX JT - ALTEX JID - 100953980 SB - IM MH - Animal Testing Alternatives/*methods/standards MH - Animal Welfare MH - Animals MH - Consumer Product Safety/legislation & jurisprudence MH - *European Union MH - Female MH - *Local Lymph Node Assay MH - Mice MH - Pilot Projects MH - Risk Assessment/methods EDAT- 2011/06/01 06:00 MHDA- 2011/09/21 06:00 CRDT- 2011/06/01 06:00 PHST- 2011/06/01 06:00 [entrez] PHST- 2011/06/01 06:00 [pubmed] PHST- 2011/09/21 06:00 [medline] AID - 10.14573/altex.2011.2.117 [doi] PST - ppublish SO - ALTEX. 2011;28(2):117-29. doi: 10.14573/altex.2011.2.117.